AMPHASTAR PHARMACEUTICALS IN (AMPH) Earnings History & Surprises

NASDAQ:AMPH • US03209R1032

Current stock price

19 USD
-0.51 (-2.61%)
At close:
19 USD
0 (0%)
After Hours:

AMPH Earnings overview

Past quarterly earnings results for AMPHASTAR PHARMACEUTICALS IN (AMPH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.74
Revenue Estimate
177.57M

Last Reported

Most Recent
Release Date
Feb 26, 2026
Period
Q4 / 2025
EPS Reported
$0.73
EPS Surprise
-22.40%
Revenue Surprise
-5.76%

Beat Rate

Last 8 Quarters
44%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 0.73 0.94 -22.40% -20.65% 183.105M 194.29M -5.76% -1.83%
Q3 2025 0.93 0.84 10.58% -3.12% 191.84M 188.42M 1.82% 0.33%
Q2 2025 0.85 0.76 12.46% -9.57% 174.414M 176.81M -1.36% -4.38%
Q1 2025 0.74 0.70 5.65% -28.85% 170.528M 174.78M -2.43% -0.76%
Q4 2024 0.92 0.96 -4.55% 4.55% 186.523M 192.04M -2.87% 4.73%
Q3 2024 0.96 1.01 -4.74% -16.52% 191.214M 198.59M -3.71% 5.90%
Q2 2024 0.94 0.79 19.17% 44.62% 182.394M 174.36M 4.61% 25.17%
Q1 2024 1.04 0.98 6.52% 67.74% 171.836M 177.51M -3.20% 22.72%
Q4 2023 0.88 0.94 -6.79% 20.55% 178.105M 179M -0.50% 31.93%
Q3 2023 1.15 0.71 62.28% 202.63% 180.556M 178.12M 1.37% 50.34%
Q2 2023 0.65 0.57 13.74% 66.67% 145.712M 140.12M 3.99% 17.99%
Q1 2023 0.62 0.48 27.86% 31.91% 140.022M 136.85M 2.32% 16.30%
Q4 2022 0.73 0.41 76.19% 73.81% 135M 129.52M 4.23% 11.66%
Q3 2022 0.38 0.40 -5.52% -17.39% 120.1M 128.9M -6.83% 7.04%
Q2 2022 0.39 0.35 9.87% 85.71% 123.5M 120.42M 2.56% 21.44%
Q1 2022 0.47 0.37 28.00% 74.07% 120.4M 115.97M 3.82% 16.89%
Q4 2021 0.42 0.37 13.85% 162.50% 120.9M 113.87M 6.17% 26.07%
Q3 2021 0.46 0.25 85.34% 206.67% 112.2M 105.31M 6.54% 34.53%
Q2 2021 0.21 0.21 -1.17% 31.25% 101.7M 103.41M -1.65% 18.53%
Q1 2021 0.27 0.19 43.64% 58.82% 103M 99.207M 3.82% 21.61%
Q4 2020 0.16 0.14 14.38% - 95.9M 90.717M 5.71% -
Q3 2020 0.15 0.14 4.72% - 83.4M 93.088M -10.41% -
Q2 2020 0.16 0.14 15.59% - 85.8M 88.348M -2.88% -
Q1 2020 0.17 0.09 93.80% - 84.7M 84.631M 0.08% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AMPH EPS Q2Q GrowthAMPH EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 50 100 150 200

Revenue Historical Q2Q growth and Acceleration

AMPH Revenue Q2Q GrowthAMPH Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 10 20 30 40 50

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
6.04%
Max EPS beat (4)
12.46%
Min EPS beat (4)
-4.55%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-1.21%
Max Revenue beat (4)
1.82%
Min Revenue beat (4)
-2.87%

Analysis

In the last 4 quarters, AMPH has beaten EPS estimates in 3 out of 4 releases
AMPH has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, AMPH has beaten the EPS estimates by 6.0% on average.
In the last 4 quarters, AMPH reported -1.2% below the revenue estimates on average.
AMPH Overview AMPH Technical Analysis Report AMPH Fundamental Analysis Report AMPH Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

AMPHASTAR PHARMACEUTICALS IN / AMPH Earnings FAQ

What is the most recent earnings date for AMPH stock?

AMPHASTAR PHARMACEUTICALS IN (AMPH) last reported earnings on 2/26/2026.

Did AMPHASTAR PHARMACEUTICALS IN (AMPH) beat earnings estimates last quarter?

AMPHASTAR PHARMACEUTICALS IN (AMPH) missed EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often AMPHASTAR PHARMACEUTICALS IN beats earnings estimates?

In the last 4 quarters, AMPHASTAR PHARMACEUTICALS IN (AMPH) has beaten EPS estimates in 3 out of 4 releases.